FINVX | SIDRX | FINVX / SIDRX | |
Total Expense Ratio | 0.01 | 0.76 | 1% |
Annual Report Gross Expense Ratio | 0.01 | 0.76 | 1% |
Fund Existence | 16 years | 10 years | - |
Gain YTD | 26.174 | 21.508 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.9B | 2.31B | 687% |
Annual Yield % from dividends | 3.73 | 2.59 | 144% |
Returns for 1 year | 21.39 | 19.02 | 112% |
Returns for 3 years | 54.99 | 33.74 | 163% |
Returns for 5 years | 107.26 | 69.30 | 155% |
Returns for 10 years | 87.83 | 70.12 | 125% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MNHRX | 25.79 | N/A | N/A |
Manning & Napier Pro-Blend Max Term R | |||
FBTTX | 23.77 | N/A | N/A |
Fidelity Advisor Biotechnology M | |||
FEYTX | 27.31 | N/A | N/A |
Fidelity Advisor Asset Manager 85% M | |||
EEMGX | 8.78 | N/A | N/A |
MFS Emerging Markets Equity Research R4 | |||
GQFIX | 12.16 | N/A | N/A |
GQG Partners Global Quality Value Fd Ins |